Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. AbbVie Inc.
483
•AbbVie Inc.•July 2, 2018

AbbVie Inc. – FDA 483, Jul 2, 2018

Record Details

An FDA inspection conducted at AbbVie Inc.'s Corporate Headquarters in North Chicago, IL, from May 15 to July 2, 2018, revealed significant issues related to adverse drug experience reporting and data system validation. The primary observation was the failure to report all serious and unexpected adverse drug experiences to the FDA within the mandated 15-calendar-day timeframe. Investigators identified approximately 482 late initial and/or follow-up Individual Case Safety Reports (ICSRs) and 15-Day Alert Reports between October 2014 and May 2018. A notable 119 of these reports were delayed by at least 100 days, with some exceeding 700 days. Products affected included Viekira XR, Venclexta, Technivie, Duopa, Viekira Pak, and Mavyret, with Duopa accounting for approximately 250 late cases. Furthermore, the inspection noted that the computer system used to manage these late ICSRs was not validated and lacked essential security controls, as users were not required to log in with a user ID or password. These findings indicate a systemic breakdown in AbbVie's pharmacovigilance processes, falling short of regulatory expectations for timely and secure adverse event reporting. AbbVie is required to address these observations by implementing corrective actions to ensure compliance with federal reporting regulations.

Company
AbbVie Inc.
Inspection date
July 2, 2018
Product type
drugs
Office
Chicago District Office
People
  • Vicki R. Edwards (Vice President)
  • Lequita Mayhew (Quality Program Specialist/Program Analyst)
View Company Profile

ID · 3b96cb46-4514-4018-a787-d89fad0a8d6f

Other documents for AbbVie Inc.
  • 483 - 2023-01-31January 31, 2023
  • EIR - 2021-12-15December 15, 2021
  • EIR - 2019-02-15February 15, 2019
  • EIR - 2018-07-02July 2, 2018
  • EIR - 2017-12-15December 15, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AbbVie Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.